Mitochondrial DNA mutations and respiratory chain dysfunction in idiopathic and connective tissue disease-related lung fibrosis

被引：0

作者：

Jaeger, V. K. ^{[1
]}

Lebrecht, D. ^{[2
,3
]}

Nicholson, A. G. ^{[4
,5
]}

Wells, A. ^{[5
,6
]}

Bhayani, H. ^{[7
]}

Gazdhar, A. ^{[8
]}

Tamm, M. ^{[9
]}

Venhoff, N. ^{[2
]}

Geiser, T. ^{[8
]}

Walker, U. A. ^{[1
]}

机构：

[1] Univ Hosp Basel, Dept Rheumatol, Basel, Switzerland

[2] Univ Freiburg, Fac Med, Dept Rheumatol & Clin Immunol, Med Ctr, Freiburg, Germany

[3] Univ Freiburg, Fac Med, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol,Med Ctr, Freiburg, Germany

[4] Royal Brompton & Harefield NHS Fdn Trust, Dept Histopathol, London, England

[5] Imperial Coll London, Natl Heart & Lung Inst, London, England

[6] Royal Brompton & Harefield NHS Fdn Trust, Interstitial Lung Dis Unit, Royal Brompton Hosp, London, England

[7] Royal Brompton & Harefield NHS Fdn Trust, London, England

[8] Univ Hosp Bern, Dept Pulm Med, Bern, Switzerland

[9] Univ Hosp Basel, Dept Pneumol, Basel, Switzerland

来源：

SWISS MEDICAL WEEKLY | 2018年 / 148卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SSRP 3

引用

页码：9S / 10S

页数：2

共 50 条

[41] Clinical characteristics of patients with connective tissue disease-related interstitial lung disease: a retrospective analysis
Colak, Seda
Tekgoz, Emre
Gunes, Ezgi Cimen
Ocal, Nesrin
Dogan, Deniz
Tasci, Canturk
Cinar, Muhammet
Yilmaz, Sedat
CLINICAL RHEUMATOLOGY, 2024, 43 (05) : 1693 - 1701
[42] Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data
Alejandro Robles-Perez
Jordi Dorca
Ivan Castellví
Joan Miquel Nolla
Maria Molina-Molina
Javier Narváez
Rheumatology International, 2020, 40 : 719 - 726
[43] Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease
Swigris, Jeffrey J.
Yorke, Janelle
Sprunger, David B.
Swearingen, Christopher
Pincus, Theodore
du Bois, Roland M.
Brown, Kevin K.
Fischer, Aryeh
RESPIRATORY MEDICINE, 2010, 104 (09) : 1350 - 1355
[44] Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data
Robles-Perez, Alejandro
Dorca, Jordi
Castellvi, Ivan
Nolla, Joan Miquel
Molina-Molina, Maria
Narvaez, Javier
RHEUMATOLOGY INTERNATIONAL, 2020, 40 (05) : 719 - 726
[45] Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment
Niranjan Jeganathan
Matheni Sathananthan
Lung, 2020, 198 : 735 - 759
[46] PREVALENCE OF IMMUNOSUPPRESSANTS AND ANTIFIBROTIC USE IN PATIENTS WITH CONNECTIVE TISSUE DISEASE-RELATED INTERSTITIAL LUNG DISEASE
Yang, J.
Sadowski, K.
Olson, A.
Kulkarni, T.
VALUE IN HEALTH, 2024, 27 (06) : S28 - S28
[47] Microvascular alterations of the ocular surface and retina in connective tissue disease-related interstitial lung disease
Chen, Li-Ming
Kang, Min
Wang, Jun-Yi
Xu, San-Hua
Chen, Cheng
Wei, Hong
Ling, Qian
He, Liang-Qi
Zou, Jie
Wang, Yi-Xin
Chen, Xu
Ying, Ping
Huang, Hui
Shao, Yi
Wu, Rui
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (10) : 1869 - 1879
[48] Connective tissue disease-related pulmonary arterial hypertension
Thakkar, Vivek
Lau, Edmund M. T.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (01): : 22 - 38
[49] Nintedanib and its combination with immunosuppressives in connective tissue disease-related interstitial lung diseases
Tekgoz, Emre
Colak, Seda Yurumez
Gunes, Ezgi Cimen
Ocal, Nesrin
Cinar, Muhammet
Yilmaz, Sedat
IRISH JOURNAL OF MEDICAL SCIENCE, 2025, 194 (01) : 391 - 397
[50] Lung cancer development in patients with connective tissue disease-related interstitial lung disease A retrospective observational study
Enomoto, Yasunori
Inui, Naoki
Yoshimura, Katsuhiro
Nishimoto, Koji
Mori, Kazutaka
Kono, Masato
Fujisawa, Tomoyuki
Enomoto, Noriyuki
Nakamura, Yutaro
Iwashita, Toshihide
Suda, Takafumi
MEDICINE, 2016, 95 (50) : e5716

← 1 2 3 4 5 →